Search: WFRF:(Van der Velden A. W.) >
Melphalan, predniso...
Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma.
- Article/chapterEnglish2016
Publisher, publication year, extent ...
-
American Society of Hematology,2016
Numbers
-
LIBRIS-ID:oai:lup.lub.lu.se:1686aaa9-7dd3-458b-9214-7ca95c1b0f0e
-
https://lup.lub.lu.se/record/8573967URI
-
https://doi.org/10.1182/blood-2015-11-679415DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:133289284URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:art swepub-publicationtype
-
Subject category:ref swepub-contenttype
Notes
-
The combination of melphalan, prednisone and thalidomide (MPT) is considered standard therapy for newly diagnosed patients with multiple myeloma (NDMM) who are ineligible for stem-cell transplantation. Long term treatment with thalidomide is hampered by neurotoxicity. Melphalan, prednisone and lenalidomide, followed by lenalidomide maintenance therapy showed promising results, without severe neuropathy emerging. We randomly assigned 668 NDMM patients, ineligible for stem-cell transplantation, between nine 4-weekly cycles of MPT followed by thalidomide maintenance until disease progression or unacceptable toxicity (MPT-T) and the same MP regimen with thalidomide being replaced by lenalidomide (MPR-R). This multicenter, open-label, randomised phase 3 trial was undertaken by HOVON and the NMSG. The primary endpoint was progression-free survival (PFS). The accrual for the study was completed in October 19, 2012. 318 patients were randomly assigned to receive MPT-T and 319 MPR-R. After a median follow up of 36 months PFS with MPT-T was 20 months (95% CI 18-23 months) versus 23 months (95% CI 19-27 months) with MPR-R (HR 0.87 [0.72-1.04], p=0.12). Response rates were similar, with ≥VGPR 47% and 45% respectively. Hematological toxicity was more pronounced with MPR-R, especially grade 3 and 4 neutropenia: 64 versus 27%. Neuropathy ≥ grade 3 was significantly higher in the MPT-T arm; 16% versus 2% in MPR-R, resulting in a significant shorter duration of maintenance therapy (5 versus 17 months in MPR-R), irrespective of age. MPR-R has no advantage over MPT-T concerning efficacy. The toxicity profile differed with clinically significant neuropathy during thalidomide maintenance versus myelosuppression with MPR.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
van der Holt, Bronno
(author)
-
Mellqvist, Ulf-Henrik
(author)
-
Salomo, Morten
(author)
-
Bos, Gerard M J
(author)
-
Levin, Mark-David
(author)
-
Visser-Wisselaar, Heleen
(author)
-
Hansson, MarkusLund University,Lunds universitet,Avdelningen för hematologi och transfusionsmedicin,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Hematology and Transfusion Medicine,Department of Laboratory Medicine,Faculty of Medicine(Swepub:lu)hema-mha
(author)
-
van der Velden, Annette W G
(author)
-
Deenik, Wendy
(author)
-
Gruber, Astrid
(author)
-
Coenen, Juleon L L M
(author)
-
Plesner, Torben
(author)
-
Klein, Saskia K
(author)
-
Tanis, Bea C
(author)
-
Szatkowski, Damian L
(author)
-
Brouwer, Rolf E
(author)
-
Westerman, Matthijs
(author)
-
Leys, M Rineke B L
(author)
-
Sinnige, Harm A M
(author)
-
Haukås, Einar
(author)
-
van der Hem, Klaas G
(author)
-
Durian, Marc F
(author)
-
Mattijssen, E Vera J M
(author)
-
van de Donk, Niels W C J
(author)
-
Stevens-Kroef, Marian J P L
(author)
-
Sonneveld, Pieter
(author)
-
Waage, Anders
(author)
-
Avdelningen för hematologi och transfusionsmedicinInstitutionen för laboratoriemedicin
(creator_code:org_t)
Related titles
-
In:Blood: American Society of Hematology127:9, s. 1109-11161528-00200006-4971
Internet link
Find in a library
-
Blood
(Search for host publication in LIBRIS)
To the university's database
- By the author/editor
-
Zweegman, Sonja
-
van der Holt, Br ...
-
Mellqvist, Ulf-H ...
-
Salomo, Morten
-
Bos, Gerard M J
-
Levin, Mark-Davi ...
-
show more...
-
Visser-Wisselaar ...
-
Hansson, Markus
-
van der Velden, ...
-
Deenik, Wendy
-
Gruber, Astrid
-
Coenen, Juleon L ...
-
Plesner, Torben
-
Klein, Saskia K
-
Tanis, Bea C
-
Szatkowski, Dami ...
-
Brouwer, Rolf E
-
Westerman, Matth ...
-
Leys, M Rineke B ...
-
Sinnige, Harm A ...
-
Haukås, Einar
-
van der Hem, Kla ...
-
Durian, Marc F
-
Mattijssen, E Ve ...
-
van de Donk, Nie ...
-
Stevens-Kroef, M ...
-
Sonneveld, Piete ...
-
Waage, Anders
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Hematology
- Articles in the publication
-
Blood
- By the university
-
Lund University
-
Karolinska Institutet